Cargando…
Late gadolinium enhancement in pulmonary hypertension predicts clinical events
Autores principales: | Soma, Siva Kumar, Goyal, Vishal, Rathi, Vikas K, Doyle, Mark, Murali, Srinivas, Vido, Diane A, Benza, Raymond, Sokos, George, Biederman, Robert W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305747/ http://dx.doi.org/10.1186/1532-429X-14-S1-P86 |
Ejemplares similares
-
LGE in pulmonary hypertension predicts clinical events
por: Soma, Siva, et al.
Publicado: (2011) -
Can cardiac MRI be the index metric for risk stratification in dilated cardiomyopathy; the impact of an LV mid-myocardial stripe on subsequent risk of LVAD, transplantation and death
por: Venero, Jose, et al.
Publicado: (2012) -
RV fibrosis in pulmonary hypertension impact on prognosis; does formal quantitation augment prognosis?
por: Soma, Siva Kumar R, et al.
Publicado: (2013) -
Does late gadolinium enhancement still have value for the RV? RV internal mechanical work, E(a)/E(max) (VVC) and LGE as prognostic markers in pulmonary hypertension; a CMR study
por: Abouelnour, Amr E, et al.
Publicado: (2016) -
Mid wall fibrosis on CMR with late gadolinium enhancement may predict prognosis for LVAD and transplantation risk in patients with newly diagnosed dilated cardiomyopathy—preliminary observations from a high‐volume transplant centre
por: Venero, Jose V., et al.
Publicado: (2015)